Search

everythinglearnresearchcommunity

for

Search:↓

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Estrogen therapy can reduce skin aging but has cancer risks.

Testosterone's muscle-building effects do not require its conversion to DHT.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Layer-by-Layer self-assembly is promising for biomedical uses like tissue engineering and cell therapy, but challenges remain in material safety and process optimization.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Polyamines help fix DNA damage accurately in cells.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.